Stock Earnings

Question 1

Karyopharm Therapeutics Incの主要な財務諸表は何ですか？

Accepted Answer

最新の財務諸表（Form-10K）によると、Karyopharm Therapeutics Incの総資産は$164で、純lossは$-76です。

Question 2

KPTIの主要な財務比率は何ですか？

Accepted Answer

Karyopharm Therapeutics Incの流動比率は0.46、純利益率は-52.41、1株当たり売上高は$17.84です。

Question 3

Karyopharm Therapeutics Incの収益はセグメントまたは地域別にどのように分けられていますか？

Accepted Answer

Karyopharm Therapeutics Inc largest revenue segment is Drugs, at a revenue of 145,237,000 in the most earnings release.For geography, United States is the primary market for Karyopharm Therapeutics Inc, at a revenue of 145,237,000.

Question 4

Karyopharm Therapeutics Incは収益を上げていますか？

Accepted Answer

no、最新の財務諸表によると、Karyopharm Therapeutics Incの純lossは$-76です。

Question 5

Karyopharm Therapeutics Incに負債はありますか？

Accepted Answer

yes、Karyopharm Therapeutics Incの負債は350です。

Question 6

Karyopharm Therapeutics Incの発行済株式数は何株ですか？

Accepted Answer

Karyopharm Therapeutics Incの総発行済株式数は8.41株です。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	137	145	146	157	209	108
Revenue Growth (YoY)	-6%	-1%	-7%	-25%	94%	170%
Cost of Revenue	4	6	4	5	3	2
Gross Profit	132	139	141	151	206	105
Selling, General & Admin	110	115	131	145	143	126
Research & Development	136	143	138	148	160	150
Operating Expenses	247	258	270	294	304	277
Other Non Operating Income (Expenses)	31	28	0	0	0	0
Pretax Income	-123	-76	-142	-164	-123	-196
Income Tax Expense	0	0	0	0	0	0
Net Income	-123	-76	-143	-165	-124	-196
Net Income Growth	38%	-47%	-13%	33%	-37%	-2%
Shares Outstanding (Diluted)	8.62	8.12	7.61	5.45	5.01	4.8
Shares Change (YoY)	-16%	7%	40%	9%	4%	16%
EPS (Diluted)	-14.33	-9.4	-18.79	-30.28	-24.74	-40.86
EPS Growth	64%	-50%	-38%	22%	-39%	-15%
Free Cash Flow	-102	-127	-92	-149	-107	-160
Free Cash Flow Per Share	-11.83	-15.63	-12.08	-27.29	-21.33	-33.31
Gross Margin	96.35%	95.86%	96.57%	96.17%	98.56%	97.22%
Operating Margin	-83.94%	-82.06%	-88.35%	-90.44%	-46.88%	-158.33%
Profit Margin	-89.78%	-52.41%	-97.94%	-105.09%	-59.33%	-181.48%
Free Cash Flow Margin	-74.45%	-87.58%	-63.01%	-94.9%	-51.19%	-148.14%
EBITDA	-115	-119	-129	-142	-98	-171
EBITDA Margin	-83.94%	-82.06%	-88.35%	-90.44%	-46.88%	-158.33%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-115	-119	-129	-142	-98	-171
EBIT Margin	-83.94%	-82.06%	-88.35%	-90.44%	-46.88%	-158.33%
Effective Tax Rate	0%	0%	0%	0%	0%	0%

Karyopharm Therapeutics Inc (KPTI) Price

KPTI Stock Price Chart

KPTI Income

Follow-Up Questions